PS52: ACNE, ROSACEA, FOLLICULITIS, PERIORAL DERMATITIS AND THEIR IMPACT ON MENTAL HEALTH

Lobby

AUTHORS
Laura Lukavičiūtė1, Petras Navickas1, Rūta Gancevičienė2,3, Alvydas Navickas4

1Vilnius University Medical Faculty, Vilnius, Lithuania
2Centre of Dermatovenereology, Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
3Vilnius University Medical Faculty Dermatovenereologic Clinic, Vilnius, Lithuania
4Vilnius University Medical Faculty Psychiatric Clinic, Vilnius, Lithuania

ABSTRACT DESCRIPTION

Aim: To determine the prevalence of anxiety, depression symptomatology, suicidal ideation and to evaluate the impact on quality of life among patients with facial dermatoses.

Methods: An observational study was conducted to evaluate the mental health and quality of life of patients with facial dermatoses using an adapted Hospital Anxiety and Depression Scale (HADS), the Dermatology Quality of Life Index (DLQI) and demography related questions.

Results: A total of 427 respondents (77.8% females, 22.2% males) participated. 255 of them had acne, 94 – rosacea, 38 – folliculitis, 40 – perioral dermatitis. 96.5% of acne patients had a reduced quality of life, similarly 92.6% – of rosacea patients, 84.2% – of folliculitis patients, 92.5% – of perioral dermatitis patients. Anxiety symptomatology was present in 38.4% patients with acne, 37.2% – with rosacea, 31.6% – with folliculitis, 32.5% – with perioral dermatitis. It was determined that 23.1% of patients with acne, 31.9% with rosacea, 18.4% with folliculitis had depression symptomatology and it was not present in the group of patients with perioral dermatitis. The skin lesion was considered the cause of suicidal ideation in 12.9% of patients with acne, 6.4% – with rosacea, 15.8% – with folliculitis, 2.5% – with perioral dermatitis. The most significant impairment to life quality and the most severe anxiety symptomatology was among acne patients – the average score was 10.6 (DLQI) and 6.68 (HADS–A). The most severe depression symptomatology was present among rosacea patients – the average score was 4.95 (HADS–D). A statistically significant mild positive correlation was found between the evaluation of rosacea severity and DLQI (rho=0.289, p=0.005), anxiety severity (rho=0.262, p=0.01), depression severity (rho=0.366, p<0.001). There was a statistically significant correlation between DLQI and anxiety severity (rho=0.345 – 0.6) and DLQI and depression severity (rho=0.302 – 0.602) amongst all four dermatoses, except for correlation between perioral dermatitis and depression severity. Furthermore, there was a statistically significant correlation between anxiety and depression severity in all the skin lesions (rho=0.429 – 0.867).

Conclusions: The most significant impairment to life quality and the most severe anxiety symptomatology presented among acne patients. The most severe depression symptomatology was presented amongst rosacea patients, while folliculitis was the most frequent cause of suicidal thoughts. The lowest prevalence of anxiety, depression symptomatology, impaired life quality and suicidal thoughts was amongst perioral dermatitis patients.

Poster Session